Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Prabha Shrestha, Yana Astter, David A. Davis, Ting Zhou, Constance M. Yuan, Ramya Ramaswami, Hao-Wei Wang, Kathryn Lurain & Robert Yarchoan. (2023) Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease. OncoImmunology 12:1.
Read now
Read now
Ayenew Berhan, Biruk Bayleyegn & Zegeye Getaneh. (2022) HIV/AIDS Associated Lymphoma: Review. Blood and Lymphatic Cancer: Targets and Therapy 12, pages 31-45.
Read now
Read now
Cristian Aguilar, Caddie Laberiano, Brady Beltran, Cecilia Diaz, Alvaro Taype-Rondan & Jorge J. Castillo. (2020) Clinicopathologic characteristics and survival of patients with primary effusion lymphoma. Leukemia & Lymphoma 61:9, pages 2093-2102.
Read now
Read now
Articles from other publishers (36)
Lyndsey N. Moore, Daniel L. Holmes, Anjali Sharma, Joselyn Landazuri Vinueza & Michael Lagunoff. (2023) Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis. PLOS Pathogens 19:5, pages e1011385.
Crossref
Crossref
Xiaojuan Li, Fan Wang, Xiaolin Zhang, Qinqin Sun & Ersheng Kuang. (2023) Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition. PLOS Pathogens 19:1, pages e1011103.
Crossref
Crossref
Misbahuddin M Rafeeq, Alaa Hamed Habib, Alaa F. Nahhas, Najat Binothman, Majidah Aljadani, Jawaher Almulhim, Ziaullah M Sain, Mohammad Zubair Alam, Norah A Alturki, Qamre Alam, Manish Manish & Rajnish Kumar Singh. (2023) Targeting Kaposi’s sarcoma associated herpesvirus encoded protease (ORF17) by a lysophosphatidic acid molecule for treating KSHV associated diseases. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Loveleen Mangla, Chayan Chakrabarty & Deepak Talwar. (2023) T-cell Lymphoma: A Rare Malignancy Masquerading as Tuberculosis. The Indian Journal of Chest Diseases and Allied Sciences 64:4, pages 272-276.
Crossref
Crossref
Michelle Böni, Lisa Rieble & Christian Münz. (2022) Co-Infection of the Epstein–Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus. Viruses 14:12, pages 2709.
Crossref
Crossref
Olga García Ruiz, José Manuel Sánchez-Maldonado, Miguel Ángel López-Nevot, Paloma García, Angelica Macauda, Francisca Hernández-Mohedo, Pedro Antonio González-Sierra, Manuel Martínez-Bueno, Eva Pérez, Fernando Jesús Reyes-Zurita, Daniele Campa, Federico Canzian, Manuel Jurado, Juan José Rodríguez-Sevilla & Juan Sainz. (2022) Autophagy in Hematological Malignancies. Cancers 14:20, pages 5072.
Crossref
Crossref
Jutatip Panaampon, Ryusho Kariya & Seiji Okada. (2022) Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cells. Cancer Immunology, Immunotherapy 71:10, pages 2497-2509.
Crossref
Crossref
Moataz Soliman, Nicholas Guys, Peter Liu, Mariam Moshiri, Christine O. Menias, Vincent M. Mellnick, Hatice Savas, Mohamed Badawy, Khaled M. Elsayes & Ayman H. Gaballah. (2022) Multimodality imaging findings of infection-induced tumors. Abdominal Radiology 47:11, pages 3930-3953.
Crossref
Crossref
Wayne W. Yeh, Yin-Quan Chen, Wan-Shan Yang, Yung-Chih Hong, Sen Kao, Tze-Tze Liu, Ting-Wen Chen, Lung Chang & Pei-Ching Chang. (2022) SUMO Modification of Histone Demethylase KDM4A in Kaposi’s Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma. Journal of Virology 96:16.
Crossref
Crossref
Wamidh H. Talib, Safa Daoud, Asma Ismail Mahmod, Reem Ali Hamed, Dima Awajan, Sara Feras Abuarab, Lena Hisham Odeh, Samar Khater & Lina T. Al Kury. (2022) Plants as a Source of Anticancer Agents: From Bench to Bedside. Molecules 27:15, pages 4818.
Crossref
Crossref
Anindita Ghosh, Rodrick Chitaurirwa Zvavanjanja & Joshua Baalwa. (2022) An Unusual Presentation of Extracavitary Primary Effusion Lymphoma: Internal Jugular Vein Occlusion, Intractable Symptoms of Intracranial Hypertension, and Prolonged Remission after Highly Active Antiretroviral Therapy. Case Reports in Hematology 2022, pages 1-6.
Crossref
Crossref
Philip T. Lange, Maria C. White & Blossom Damania. (2022) Activation and Evasion of Innate Immunity by Gammaherpesviruses. Journal of Molecular Biology 434:6, pages 167214.
Crossref
Crossref
Hsueh-Chien Chiang, Shih-Chieh Chien & Yih-Jyh Lin. (2022) Pleural Effusion With Gastric Ulcer. Gastroenterology 162:2, pages e16-e19.
Crossref
Crossref
Diamone Gathers, Emily Galloway, Katalin Kelemen, Allison Rosenthal, Sarah Gibson & Javier Munoz. (2022) Primary Effusion Lymphoma: A Clinicopathologic Perspective. Cancers 14:3, pages 722.
Crossref
Crossref
Tomohiro Nishimori, Tomonori Higuchi, Yumiko Hashida, Takako Ujihara, Ayuko Taniguchi, Fumiya Ogasawara, Naoya Kitamura, Ichiro Murakami, Kensuke Kojima & Masanori Daibata. (2021)
Development of a novel cell line‐derived xenograft model of primary herpesvirus 8‐unrelated effusion large B‐cell lymphoma and antitumor activity of birabresib
in vitro
and
in vivo
. Cancer Medicine 10:24, pages 8976-8987.
Crossref
Crossref
Miriam Verdu-Bou, Gustavo Tapia, Agueda Hernandez-Rodriguez & Jose-Tomas Navarro. (2021) Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas. Cancers 13:21, pages 5534.
Crossref
Crossref
Yessica Sánchez-Ponce & Ezequiel M. Fuentes-Pananá. (2021) The Role of Coinfections in the EBV–Host Broken Equilibrium. Viruses 13:7, pages 1399.
Crossref
Crossref
Roberta Santarelli, Chiara Pompili, Maria Saveria Gilardini Montani, Maria Anele Romeo, Roberta Gonnella, Gabriella D'Orazi & Mara Cirone. (2021)
Lovastatin reduces
PEL
cell survival by phosphorylating
ERK1
/2 that blocks the autophagic flux and engages a cross‐talk with p53 to activate p21
. IUBMB Life 73:7, pages 968-977.
Crossref
Crossref
Marta Kasprzyk, Weronika Sura & Agnieszka Dzikiewicz-Krawczyk. (2021) Enhancing B-Cell Malignancies—On Repurposing Enhancer Activity towards Cancer. Cancers 13:13, pages 3270.
Crossref
Crossref
Ofir Koren, Ariel Aviv, Moran Avraham Kelbert, Ehud Rozner, Liza Lihtman, Elya Halfin & Yoav Turgeman. (2021) Primary effusion lymphoma in a patient with a good outcome on steroid alone treatment. Clinical Case Reports 9:4, pages 2305-2309.
Crossref
Crossref
Guang-Liang Chen, Zu-Guang Xia, Jia Jin, Bao-Hua Yu & Junning Cao. (2021) Characterization of Artificial Pneumothorax-Unrelated Pyothorax-Associated Lymphoma. Journal of Oncology 2021, pages 1-7.
Crossref
Crossref
Francesca Sanguedolce, Magda Zanelli, Maurizio Zizzo, Alessandra Bisagni, Alessandra Soriano, Giorgia Cocco, Andrea Palicelli, Giacomo Santandrea, Cecilia Caprera, Matteo Corsi, Giulia Cerrone, Raffaele Sciaccotta, Giovanni Martino, Linda Ricci, Francesco Sollitto, Domenico Loizzi & Stefano Ascani. (2021) Primary Pulmonary B-Cell Lymphoma: A Review and Update. Cancers 13:3, pages 415.
Crossref
Crossref
Yosuke Sazumi, Kazuki Tokumasu, Hideharu Hagiya & Fumio Otsuka. (2020) Without a silhouette. Clinical Case Reports 9:1, pages 574-575.
Crossref
Crossref
Abram Calderon, Samantha S. Soldan, Alessandra De Leo, Zhong Deng, Drew M. Frase, Emma M. Anderson, Yue Zhang, Olga Vladimirova, Fang Lu, Jessica C. Leung, Maureen E. Murphy & Paul M. Lieberman. (2020) Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism. Oncotarget 11:46, pages 4224-4242.
Crossref
Crossref
Darakhshan Sohail Ahmed, Marc Poliquin, Louis-André Julien & Jean-Pierre Routy. (2020) Extracavitary primary effusion lymphoma recurring with syphilis in an HIV-infected patient. BMJ Case Reports 13:11, pages e235204.
Crossref
Crossref
May Fu, Malary Mani, Jaclyn Bradford, Weina Chen, Mingyi Chen & Franklin Fuda. (2020) Application of flow cytometry in the analysis of lymphoid disease in the lung and pleural space. Seminars in Diagnostic Pathology 37:6, pages 303-320.
Crossref
Crossref
Flavia Rosado, Ling Guo & Franklin Fuda. (2020) Hematolymphoid neoplasms with a plasma cell phenotype. Seminars in Diagnostic Pathology 37:6, pages 268-272.
Crossref
Crossref
Sara Moodad, Rana El Hajj, Rita Hleihel, Layal Hajjar, Nadim Tawil, Martin Karam, Maguy Hamie, Raghida Abou Merhi, Marwan El Sabban & Hiba El Hajj. (2020) Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma. Cancers 12:9, pages 2483.
Crossref
Crossref
Seung-Min Yoo & Myung-Shin Lee. (2020) Kaposi’s Sarcoma-Associated Herpesvirus and Host Interaction by the Complement System. Pathogens 9:4, pages 260.
Crossref
Crossref
Jiankun Tong, Sana Jadallah, William H. Rodgers, Gabriel Jung, Malvina Fulman & Abhisek Swaika. (2020) A Rare Case of Extracavitary Primary Effusion Lymphoma in the Bladder and Ureter. Case Reports in Hematology 2020, pages 1-5.
Crossref
Crossref
Francesca Locatelli, Francesca Ambrosi & Giulio Rossi. 2020. The Thorax. The Thorax
1
33
.
Laura Campogiani, Carlotta Cerva, Gaetano Maffongelli, Elisabetta Teti, Livio Pupo, Sara Vaccarini, Maria Cantonetti, Alfredo Pennica, Massimo Andreoni & Loredana Sarmati. (2019) Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir. AIDS Research and Therapy 16:1.
Crossref
Crossref
Rafael Martínez‐Girón & Santiago Martínez‐Torre. (2019) Pleural effusion in a human immunodeficiency virus‐infected patient. Cytopathology 30:6, pages 673-675.
Crossref
Crossref
Rebecca Pellett Madan & Jonathan Hand. (2019) Human herpesvirus 6, 7, and 8 in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clinical Transplantation 33:9.
Crossref
Crossref
Kristijan Skok, Gaja Hladnik, Anja Grm & Anton Crnjac. (2019) Malignant Pleural Effusion and Its Current Management: A Review. Medicina 55:8, pages 490.
Crossref
Crossref
Rabea Wagener, Cristina López & Reiner Siebert. 2019. Non-Hodgkin's Lymphoma in Childhood and Adolescence. Non-Hodgkin's Lymphoma in Childhood and Adolescence
33
50
.